Clinical Considerations in the Use of Glucagon-Like Peptide-1 Receptor Agonists for Obesity Management
{{output}}
As the prevalence of severe obesity continues to rise, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and GLP-1/glucose-dependent insulinotropic polypeptide receptor agonist combination medications offer potential for substantial weight loss. Weight los... ...
